Systemic Ang II treatment caused myocardial hypertrophy in control mice, whereas the immunized mice showed a significant mitigation of the Ang II-induced increase in the heart weight to body weight ratio (Figure 3A). This evidence concerns the gene AGT and cardiac hypertrophy.